was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4.
21 scientific presentations, including 7 late breakers, showcase the breadth of UCB s portfolio, reinforcing commitment to improving the lives of people living.